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Abstract
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Background—Pancreatic cancer is one of the most lethal cancers in the United States. This is
partly due to the difficulty in early detection of this disease as well as poor therapeutic responses
to currently available regimens. Our previous reports suggest that mucin 13 (MUC13, a
transmembrane mucin common to gastrointestinal cells) is aberrantly expressed in this disease
state, and has been implicated with a worsened prognosis and an enhanced metastatic potential in
PanCa. However, there is virtually no information currently to describe the biophysical
ramifications of this protein.
Methods—To demonstrate the biophysical effect of MUC13 in PanCa, we generated
overexpressing and knockdown model cell lines for PanCa and subsequently subjected them to
various biophysical experiments using atomic force microscopy (AFM) and cellular aggregation
studies.
Results—AFM-based nanoindentation data showed significant biophysical effects with MUC13
modulation in on PanCa cells. The overexpression of MUC13 in Panc-1 cells led to an expected
decrease in modulus, and a corresponding decrease in adhesion. With MUC13 knockdown, HPAFII cells exhibited an increased modulus and adhesion. These results were confirmed with altered
cell-cell adhesion as seen with aggregation assays.
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Conclusions—MUC13 led to significant biophysical changes in PanCa cells and which
exhibited characteristic phenotypic changes in cells demonstrated in previous work from our lab.
This work gives insight into the use of biophysical measurements that could be used to help
diagnose or monitor cancers as well as determine the effects of genetic alterations at a mechanical
level.
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1.

Introduction

Author Manuscript

Pancreatic cancer (PanCa) remains one of the deadliest cancers and leading causes of
cancer-related death in the United States, requiring additional research to improve quality of
life and survival rates. As of 2018, over 44,000 deaths were estimated out of around 55,000
new cases representing a nearly 80% mortality rate.1 Even with recent advances in surgical
techniques, chemotherapeutic regimens and radiation therapies, there is a poor 5-year
survival rate of less than 10%.2 One critical factor in this disease is the aberrant expression
of various mucins.3 These high molecular weight glycoproteins are normally expressed on
the exterior of mucosal surfaces to act as a protective barrier with the surroundings.4

Author Manuscript

One mucin of note is MUC13, a transmembrane mucin which is normally expressed at low
levels in the large intestine, trachea, kidney, small intestine, and gastric epithelium. Current
evidence in the literature suggests an aberrant expression of MUC13 has been associated
with ovarian and gastrointestinal cancers.5 Our lab has previously shown that the aberrant
expression of MUC13 is associated with an enhanced tumorigenesis both in vitro and in vivo
in ovarian cancer6, CRC7, and PanCa.8 In all three cancers, MUC13 was associated with an
increased cancer cell motility as shown through enhanced proliferation, colony formation,
invasion, and migration. In addition, MUC13 was found to be significantly overexpressed in
cancerous tissues as compared to their normal counterparts, indicating a singular role in
cancer development.6,9,10 Results from PanCa and CRC studies seem to indicate that
MUC13 expression is higher in both advanced-stage and metastatic tumor tissues.9,10
In order to better assess changes in a cell’s behavior, various biochemical assays exist to
elucidate the specific causes of these changes. There is great interest to understand
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biophysical information at an ultrastructural level to help judge cellular phenotypes. To
accomplish this, over the past few decades a new technology has emerged that allows for
biophysical characterization of cells. This technology is based on relatively recent advances
in the field of atomic force microscopy. An atomic force microscope (AFM) is a type of
scanning probe microscope that works by taking a sharp metallic probe attached to a flexible
cantilever and bringing it into contact with or a short distance above the sample’s surface
and can generate very high-resolution three-dimensional topographies. Due to the direct
interaction between the probe and the sample’s surface, it is possible to use an AFM to
perform additional analyses – one of the most widely used and promising (particularly for
biological research) is quantifying physical parameters via nanoindentation.11–13 With this
technique, the probe is brought into contact with the sample and a set deformation is applied.
A force curve is generated, and using this, several nanomechanical parameters can be
quantified (namely, Young’s modulus14,15 and adhesion16–18). Young’s modulus, also
known as the elastic modulus, is a parameter that defines a material’s stiffness, and is
defined as stress (a force applied over a given area) divided by strain (the change in a
material’s length as compared to its original dimensions). Given this parameter, it is possible
to determine key physical changes – the more force required to deform a material indicates a
higher modulus, and by contrast, a lower force to deform indicates a reduced modulus.19

Author Manuscript
Author Manuscript

The application of nanoindentation to cancer cells leads to a new and exciting technique to
help identify and potentially even diagnose cancer from a purely physical analysis.20 The
current consensus in scientific literature supports the notion that cancer cells are less rigid
(i.e., they have a lower modulus) than their healthy cellular counterparts. In addition, cells
with a higher metastatic potential have also generally been seen to have a lower rigidity as
well. 14,21 However, there is limited research on the biophysical role of mucins and virtually
none of this applied to PanCa. Therefore, we present our findings on the biophysical effects
of MUC13 via genetically modified PanCa cells with over-expressed or knocked down
MUC13 levels to determine if any significant biophysical changes can be identified. This
will then be compared to the phenotypic effect of MUC13 on cancer cells to see if the
expected correlation in literature is met.

2.
2.1.

Materials and Methods
Cell culture

Author Manuscript

Cell lines (HPNE, HPAF-II, BxPC-3, MIA PaCa-2, AsPC-1, Panc-1) were purchased from
the American Type Culture Collection (ATCC, Manassas, VA, USA) and were maintained at
37°C/5% CO2 in growth medium with 10% FBS (DMEM, Cat. No. 11965092; RPMI-1640,
Cat. No. 11875–093; DMEM/Ham’s F12, Cat. No. 11320033, Gibco). HPNE, MIA PaCa-2,
and Panc-1 cells were grown in DMEM media; BxPC-3 and AsPC-1 cells were grown in
RPMI; HPAF-II cells were grown in DMEM/F-12 media. Cells were grown in T-75 flasks
until at least 70% confluent. Next, media was aspirated under a flow hood and trypsinized at
37oC until cells were detached. The cells were then centrifuged at 1000 rpm for 5 min,
counted, and seeded as needed for the various experiments discussed below.
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Transfected models of MUC13 modulated cells for PanCa cells were generated using
previously described protocols.8 In brief, overexpressing models were generated using
Panc-1 cells transfected with Lipofectamine 2000 per manufacturer’s directions (Invitrogen).
Knockdown cell lines were created with HPAF-II transfected with MUC13 specific shRNA
lentiviral particles per manufacturer’s instructions (Sigma).
2.3.

PCR

Author Manuscript

Cells were collected and RNA was isolated using TRIzol reagent. Reverse transcription was
then conducted using High-Capacity cDNA reverse transcriptase kit (ThermoFisher)
according to manufacturer’s protocol. After collecting cDNA, it was amplified using
MUC13 and GAPDH-specific primers. Quantitative real-time PCR was done using SYBR
Green Master Mix on a Roche LightCycler.
2.4.

AFM Imaging and Nanoindentation

Author Manuscript

Cells were seeded in 60 mm dishes (Sarstedt, Model No. 83.3901, Numbrecht, Germany)
and grown to 75% confluency. The cells were then gently washed with Phosphate Buffered
Saline (PBS, 1X, pH 7.4) three times and fresh media was added. Cells were taken to the
AFM (BioScope Resolve, Bruker; Billerica,MA,USA) and placed on a heated stage (37 oC)
and allowed to equilibrate for 10–15 minutes. During this time, the probe (PFQNM-LC,
Bruker) was calibrated via thermal tune. These probes are custom-made for live cell
applications and have pre-calibrated spring constants, allowing for a simple, one-step
calibration. Once calibrated, the probe was brought into contact with a cell and a ramp test
was run to confirm proper contact. A force volume scan was then conducted over a small
group of cells (128*128 resolution, 15Hz scan rate, 400 pN force setpoint, 4 μm ramp size)
and repeated on several groups. All data was collected within a two-hour window for each
plate. Force data was then analyzed in two separate ways: firstly, over the whole cell using at
least 75% of the surface of each cell, and then a regional analysis was conducted, taking
equally sized 25 μm2 regions randomly selected at the nuclear, cytoplasmic, and peripheral
regions. This difference is visually summarized in Figure 1. The data was averaged for each
group from multiple cells in each group using NanoScope Analysis software (Bruker). These
experiments were repeated in triplicate.
2.5.

Aggregation assays

Author Manuscript

To determine the effect of MUC13 on cell-to-cell adhesion, aggregation assays were
conducted. The original protocol can be found in one of our lab’s previous publications.6
The protocol was slightly modified for use in these experiments: briefly, 20,000 cells were
suspended in a small bead of media (~25 μL) which was deposited onto the lid of a petri
dish. The base of the petri dish was filled with PBS to prevent evaporation. The lid was then
placed on the dish and incubated overnight at 37 oC. The next day the lid was inverted, and
the bead was gently pipetted to disperse any larger aggregates. Photos were then promptly
taken using optical microscopes (20x images taken on EVOS® FLoid Cell Imaging System,
Cat. No. 447136; ThermoFisher, Waltham, MA, USA).
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Analyses were conducted using unpaired, two-tailed Student’s T-tests to assess the
differences between relevant groups in the various experiments. All error bars used in the
attached figures indicate the standard error of mean (SEM). The number of stars used on
each graph relates to the level of significance - i.e., one star (*) indicates P-values below
0.05, two stars (**) values below 0.01, three stars (***) for values below 0.001, and items
with four stars (****) indicate all P-values below 0.0001.

3.
3.1.

Results
Characterization of pancreatic cell lines

Author Manuscript

In this study, MUC13 modulation was conducted on PanCa cell line models to investigate its
biophysical effects on these disease states. In order to assess the effects of MUC13, we first
investigated the baseline characteristics on a panel of normal and cancerous pancreatic cells.
Figure 2 outlines the results of analyzing this panel of cells. All cancerous cells were
considerably softer than the reference normal cell line (HPNE). In addition, there is a
noticeable trend in the cell lines with reduced differentiation status – as shown in Figure 2A,
there is a further reduction in MIA PaCa-2, AsPC-1 and Panc-1 as compared to HPAF-II and
BxPC-3, which are poorly differentiated and more well differentiated respectively.22 Some
minor differences were also seen in the membrane adhesiveness between these cells (Figure
2B), but in comparison to the large changes in membrane rigidity these were relatively
minor.

Author Manuscript

Representative force maps for these cells (shown in Figure 2C) clearly show the difference
in cellular rigidity and adhesion between these cell lines. MUC13 modulated cells were
generated using the protocols outlined in the Methods section. Using PCR analysis, altered
MUC13 expression was confirmed in these cell lines. Of the cell lines shown in Figure 2,
HPAF-II was chosen for the knockout model as our lab has previously shown it has
extensive MUC13 expression, while Panc-1 has shown minimal to no MUC13 expression,
making it an ideal candidate for an overexpression model.8
3.2.

Altered MUC13 expression exhibits significant biophysical effects on PanCa cells
Overexpression of MUC13 in Panc-1 cells (Figure 3A) gave results that theoretically agreed
with the expected trends in literature, specifically that genetic changes that cause enhanced
invasive or migratory potential reduce the cellular moduls.23,24 Panc-1 MUC13 OE cells
were significantly softer than their vector counterparts (Figure 3Bi). Overall, there was no
significant change in membrane adhesion (Figure 3Ci).

Author Manuscript

A set of HPAF-II cells with MUC13 knockdown (Figure 4A) showed the opposite effect,
i.e., an overall significant increase in was noted in the modulus (Figure 4Bi) as well as a
highly significant increase in membrane adhesiveness (Figure 4Ci).

Micron. Author manuscript; available in PMC 2021 March 01.

Massey et al.

Page 6

Author Manuscript

3.3. Differences in overall and regional nanomechanical analysis for MUC13-modulated
cells
As discussed in the Methods section and shown in Figure 1, the MUC13 modulated cells
were analyzed in an overall method (as seen in Figures 3 and 4) as well as a regional
method, where data was collected in equally sized regions at the nuclear, cytoplasmic and
peripheral regions. When looking at the regional data for Panc-1 MUC13 overexpressing
cells, a significant reduction in the modulus was noted in the nuclear and cytoplasmic
regions, and a significant reduction was noted in adhesion but only at the nuclear region
(Figure 5A). For HPAF-II MUC13 knockout cells, the modulus was found to be significantly
increased at the cytoplasmic and peripheral regions, and the cell has significantly higher
membrane adhesion at all regions of the cell (Figure 5B). The data in Figures 3,4, and 5
shows that the trend between the overall and regional analyses are similar.

Author Manuscript

3.4.

Increased MUC13 associated with reduced cellular aggregation
Aggregation assays were conducted on these cell lines to determine the effect of MUC13 on
cell-to-cell cohesion. The results of these tests indicate that MUC13 plays a potent role in
affecting this intercellular adhesion. It was shown that Panc-1 cells with overexpressed
MUC13 were only loosely grouped to one another, while the vector control consistently
stayed in tight clusters (Figure 6A). HPAF-II vector cells did show some inherent
adhesiveness; however, it was observed to be in loosely connected clumps with several
detaching cells. With MUC13 knockdown, there appeared to be a greater interconnectivity
between the cells, and a clear sheet-like layer of cells was observed (Figure 6B).

4.

Discussion

Author Manuscript

Multiple previous studies have shown that cancer cells have a reduced modulus when
compared to their normal and noncancerous counterparts.14,25,26 In addition, factors that
enhance oncogenic phenotypes have also led to reductions in cancer cell rigidity.23,27,28 It is
thought that these changes are in part due to changes in the cytoskeleton of the cell.29,30 Due
to this, several studies have been conducted investigating the biophysical differences in
cancerous and normal tissue as a means of rapid identification and diagnosis of cancer.
26,31,32

Author Manuscript

Although various studies have been published detailing the biophysical effects of various
genetic alterations or treatment with various compounds in both PanCa23,33,34 and other
gastrointestinal cancers such as CRC35, there has been no study to date investigating the
biophysical effect of MUC13 expression in these cancers. Based on the nanoindentation and
additional supporting data discussed in this section, we can conclude that differential
MUC13 expression has significant biophysical effects on PanCa cells.
As shown in Figure 2A, cancerous pancreatic cells have considerably lower rigidity
compared to the normal reference cell line (HPNE). This is in agreement with the
conventional consensus in the literature that cancerous cells are softer than their normal
counterparts.14,25,32 Although changes in membrane adhesion were also noted (Figure 2B),
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they were not as large as the changes in cell rigidity. These changes are best visualized in the
representative force maps (Figure 2C).
When observing the effect of MUC13 on the biophysical properties in these cells, PanCa
cells gave the initially anticipated result. MUC13 overexpression led to a significant
reduction in the cell modulus (Panc-1, Figure 3B), which is expected for changes leading to
an increased oncogenicity. HPAF-II cells also showed the anticipated effect with MUC13
knockdown in the form of significant increases in both modulus and adhesion (Figures
4B,C).

Author Manuscript

Of note, there is a considerable change in the base rigidity of Panc-1 and HPAF-II after
transfection has occurred. Specifically, the average rigidity of Panc-1 raised from
approximately 2kPa to nearly 8kPa after transfection with the vector plasmids. In addition,
HPAF-II dropped from around 14kPa to approximately 10kPa. It is unclear as to the exact
mechanism behind this biophysical change; however, we speculate that the effects of stable
transfection and antibiotic selection have caused considerable change in the cell which led to
significant physical changes as well. Of note, at least one study has shown that transient
transfection with siRNA led to minimal changes in biophysical properties23, however this
may be due to a lack of antibiotic selection pressure on the cells.

Author Manuscript

As mentioned above, the trends in the overall and regional analyses are similar. Regional
data examining the nuclear, cytoplasmic, and peripheral regions individually may provide a
clearer insight into some of the effects of MUC13 modulation on cancer cell phenotypes,
especially when looking at changes at the periphery of the cell. Changes at this region may
be more closely related to changes in the motility and adhesive properties in a twodimensional culture, but all regions of the cell should need to be considered for threedimensional effects, as evident by alterations in aggregation.
MUC13 seems to directly impede the ability of cells to aggregate with one another in vitro.
This may be in part to its ability to impede with the association of cadherins between cells,
impacting cell to cell adhesion and facilitating the dissociation and invasion of cancer cells
from the primary tumor. Similar results previously published from our lab indicated a similar
effect on MUC13 modified ovarian cancer cells; specifically, a reduced aggregation was
seen with MUC13 overexpression as compared to the vector.6 In addition, our lab has
previously published data indicating an interaction between MUC13 and HER2 in PanCa
cells, leading to an upregulation of its downstream pro-oncogenic pathways. This in turn is
implicated in affecting various facets of oncogenicity, including disruption of integrins at the
cell membrane, which can lead to a reduced interaction with the extracellular matrix.36

Author Manuscript

Furthermore, previous studies have shown an interaction between MUC13 and HER2 in
PanCa cells. This is of note as HER2 is thought to be activated by MUC13, and in turn
reduce the function of E-cadherin which would lower cell-cell adhesion.6,8,36 This may
partially explain why cells with overexpressed MUC13 have been shown to have enhanced
motility, as removing E-cadherin from the surface of the cell frees β-catenin, which could
then act as a transcription factor to propagate the EMT cycle.37
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As shown from previously published data from our lab, knockdown of MUC13 in HPAF-II
cells is associated with a reduction in clonogenic, invasive, migratory, and proliferative
phenotypes. This supports the notion of reduced aggressiveness with an increased cellular
modulus noted in MUC13 KO cells compared to their vector. By contrast, the
overexpression of MUC13 in Panc-1 has the opposite effect, leading to an increase in
proliferation and clonogenic potential8 - this helps to support the notion that MUC13
increases cancer cell aggressiveness and leads to a reduction in cellular rigidity. Recently,
our lab showed that in PanCa cells, MUC13 was associated with an increased glucose uptake
and metabolism via stabilizing the Glut-1 protein, allowing cancer cells to utilize more
glucose for various functions.38

Author Manuscript

Clinically, MUC13 has been shown to be associated with a poorer prognosis in PanCa. This
was shown in recent research by Khan et al, where tissue samples showed a positive
correlation between later stage disease and increased MUC13 expression. In addition,
MUC13 was more pronounced in cancerous tissue compared to normal adjacent, and
especially concentrated in higher stage (Stage III-IV) or metastatic tissue as demonstrated in
one of our lab’s previous reports.9
This effect does not appear to be limited to gastrointestinal cancers - as shown in our lab’s
previous work on ovarian cancer, MUC13 expression led to significant changes in cellular
motility.6 We can therefore hypothesize that based on the results from this study, a
significant biophysical effect would occur, but studies would need to be run to see how
MUC13 affects ovarian cancer cells.
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These results indicate the potential of AFM-based nanoindentation for use as a clinical tool
for cancer assessment. Using only the physical changes observed in tumor samples, it may
one day be possible for pathologists to determine the course of a disease state by measuring
physical changes over time and using these changes as prognostic indicators of disease
progression.

5.

Conclusion

Author Manuscript

Overall, MUC13 seems to impart significant biophysical changes associated with a
promotion of increased metastatic potential. In this paper, we assessed the biophysical
effects of MUC13 modulation on PanCa cells. These cells were first scanned in their native
configuration to determine their baseline physical characteristics. With MUC13 modulation,
significant changes were seen in the biophysical parameters for PanCa cells (modulus and
adhesion) which correlated with previous phenotypic data produced from our lab. When
taken together, these data help to show that MUC13 leads to an increased metastatic
potential, which in turn softens the cell leading to an increase in its overall motility and
reduction in cell-cell adhesion.
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Highlights
•

Pancreatic cancer is known to aberrantly express mucin protein MUC13

•

High levels of MUC13 are associated with enhanced aggressiveness in
multiple cancers

•

Nanomechanical analysis of MUC13 modulated cells shows unique
biophysical changes

•

Observed physical changes agree with literature consensus on reduced
modulus in more aggressive or invasive cells
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Figure 1: Schematic overview of different analysis methods used in this study.

Cells were scanned and analyzed for overall data (taking an average value of at least 75% of
the surface of the cell) or in a compartmentalized manner (measuring data in equally sized,
randomly selected portions of the nuclear, cytoplasmic, and peripheral regions).
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Figure 2: Characterization of normal and cancerous pancreatic cells.

(A) Modulus data for a panel of normal and cancerous pancreatic cells. (B) Adhesion data
for the pancreatic cell panel. (C) Representative force images showing relative changes in
physical parameters between cell lines.
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Figure 3: Effect of MUC13 overexpression on PanCa biophysical properties.

(A) PCR data showing increased mRNA with MUC13 overexpressed cells. (B) Effect of
MUC13 overexpression on modified Panc-1 cell rigidity (i). Representative force maps show
changes in modulus across the surface of the cell (ii). (C) Effect of MUC13 overexpression
on modified Panc-1 adhesiveness (i). Representative force maps show changes in adhesion
across the surface of the cell (ii).
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Figure 4: Effect of MUC13 knockdown on PanCa biophysical properties.

(A) PCR results showing reduced mRNA levels with MUC13 knockdown. (B) Effect of
MUC13 knockdown on rigidity of modified HPAF-II cells (i). Representative force maps
showing changes in rigidity across the surface of the cell (ii). (C) Effect of MUC13
knockdown on adhesion of modified HPAF-II cells (i). Representative force maps showing
the changes in adhesion across the surface of the cell (ii).
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Figure 5: Regional nanomechanical analysis of MUC13-modulated PanCa cells.
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(A) Regional nanoindentation data for Panc-1 MUC13 overexpressed cells showing
localized changes at the nuclear, cytoplasmic, and peripheral regions of the cell surface. (B)
Regional nanoindentation data for HPAF-II MUC13 knockdown cells showing localized
changes at the nuclear, cytoplasmic, and peripheral regions of the cell surface.
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Figure 6: Effect of MUC13 modulation on cellular aggregation.

(A) Panc-1 cells show decreased cell-cell adhesion with MUC13 overexpression. (B) HPAFII cells show increased cell-cell adhesion with MUC13 knockdown. Cells were imaged at
20x magnification. Representative groups of cells are highlighted with white squares and
magnified images are detailed on the right of each image to show detailed effect of MUC13
on cellular aggregation.
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